Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katerina Chatzidionysiou

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Mediterranean Journal of Rheumatology|November 16, 2020
The Rheumatologist's Role in the Battle Against COVID-19: Insights from the Front Line and Challenges for the FutureChristos Koutsianas, Katerina Chatzidionysiou
Clinical Rheumatology|December 15, 2019
Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?George E Fragoulis, Katerina Chatzidionysiou
Best Practice & Research. Clinical Rheumatology|February 3, 2020
Established rheumatoid arthritis - Redefining the conceptKaterina Chatzidionysiou, George E Fragoulis
RMD Open|August 16, 2019
Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shiftKaterina Chatzidionysiou, Petros P Sfikakis
Nature Reviews. Rheumatology|July 31, 2013
Rheumatoid arthritis. Triple therapy or etanercept after methotrexate failure in RA?Ronald F van Vollenhoven, Katerina Chatzidionysiou
Journal of Clinical Medicine|August 26, 2023
Intracardiac Thrombi in Morbus Adamantiades-Behçet in Two Swedish PatientsRaffaele Da Mutten, Alexander Borg, Katerina Chatzidionysiou, et al.
RMD Open|October 15, 2025
Multiple DMARD discontinuations in rheumatoid arthritis: how often and in what patients? Results from a national clinical RA registerEmma Wettersand, Daniela di Giuseppe, Johan Askling, et al.
Clinical and Experimental Rheumatology|February 24, 2023
Original research on Behçet's syndrome: a bibliometric analysis over 20 years (2000-2019)Eleana Bolla, Katerina Chatzidionysiou, Maria G Tektonidou, et al.
Clinical Rheumatology|September 29, 2020
Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?Katerina Chatzidionysiou, Matina Liapi, Georgios Tsakonas, et al.
RMD Open|October 21, 2022
Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smokingKaterina Chatzidionysiou, Daniela di Giuseppe, Jonas Soderling, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Mediterranean Journal of Rheumatology|November 16, 2020
The Rheumatologist's Role in the Battle Against COVID-19: Insights from the Front Line and Challenges for the FutureChristos Koutsianas, Katerina Chatzidionysiou
Clinical Rheumatology|December 15, 2019
Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?George E Fragoulis, Katerina Chatzidionysiou
Best Practice & Research. Clinical Rheumatology|February 3, 2020
Established rheumatoid arthritis - Redefining the conceptKaterina Chatzidionysiou, George E Fragoulis
RMD Open|August 16, 2019
Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shiftKaterina Chatzidionysiou, Petros P Sfikakis
Nature Reviews. Rheumatology|July 31, 2013
Rheumatoid arthritis. Triple therapy or etanercept after methotrexate failure in RA?Ronald F van Vollenhoven, Katerina Chatzidionysiou
Journal of Clinical Medicine|August 26, 2023
Intracardiac Thrombi in Morbus Adamantiades-Behçet in Two Swedish PatientsRaffaele Da Mutten, Alexander Borg, Katerina Chatzidionysiou, et al.
RMD Open|October 15, 2025
Multiple DMARD discontinuations in rheumatoid arthritis: how often and in what patients? Results from a national clinical RA registerEmma Wettersand, Daniela di Giuseppe, Johan Askling, et al.
Clinical and Experimental Rheumatology|February 24, 2023
Original research on Behçet's syndrome: a bibliometric analysis over 20 years (2000-2019)Eleana Bolla, Katerina Chatzidionysiou, Maria G Tektonidou, et al.
Clinical Rheumatology|September 29, 2020
Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?Katerina Chatzidionysiou, Matina Liapi, Georgios Tsakonas, et al.
RMD Open|October 21, 2022
Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smokingKaterina Chatzidionysiou, Daniela di Giuseppe, Jonas Soderling, et al.
Pageof 7